Monday January 20, 2020

Drugs firm examined by regulator after ‘shocking’ safety breaches

The Health Products Regulatory Authority (HPRA) said it was concerned and was “following up with" drug maker Astellas

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
2nd July, 2017

Ireland’s medicines regulator is assessing the possible implications for Ireland after the drugmaker Astellas was accused of “shocking” breaches of guidelines that “raised serious concerns with regard to patient safety” in Britain.

In a statement to this newspaper last week, the Health Products Regulatory Authority (HPRA) said it was concerned and was “following up with Astellas as regards any possible implications for the advertising and promotion of the company’s...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Breast screening is fallible, and with potential extra costs due to legal actions, questions about the viability of the programme are invevitable

John Crown | 1 day ago

Inquest report calls for 24-hour consultant cover after delay in treatment led to death of Wexford patient

Susan Mitchell | 1 week ago

HSE plans to implement HPV screening test ‘during Q1 this year’

Susan Mitchell | 1 week ago